Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3438816 | American Journal of Obstetrics and Gynecology | 2008 | 7 Pages |
Abstract
The economic burden of noncervical HPV disease is substantial. Analyses that assess the value of investments in HPV prevention and control programs should take into account the costs and morbidity and mortality rates that are associated with these conditions.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Delphine MD, Sue MD,